The pahtway p453 has 62 genes in the original annotation. Currently, there are 43 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
5599 | MAPK8 | JNK | JNK-46 | JNK1 | JNK1A2 | JNK21B1/2 | PRKM8 | SAPK1 | SAPK1c | mitogen-activated protein kinase 8 | | | 10q11.22 |
1147 | CHUK | IKBKA | IKK-alpha | IKK1 | IKKA | NFKBIKA | TCF16 | conserved helix-loop-helix ubiquitous kinase | | | 10q24-q25 |
3265 | HRAS | C-BAS/HAS | C-H-RAS | C-HA-RAS1 | CTLO | H-RASIDX | HAMSV | HRAS1 | RASH1 | p21ras | Harvey rat sarcoma viral oncogene homolog | | | 11p15.5 |
5970 | RELA | NFKB3 | p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | | | 11q13 |
9846 | GAB2 | - | GRB2 associated binding protein 2 | | | 11q14.1 |
867 | CBL | C-CBL | CBL2 | FRA11B | NSLL | RNF55 | Cbl proto-oncogene, E3 ubiquitin protein ligase | | | 11q23.3 |
5781 | PTPN11 | BPTP3 | CFC | JMML | METCDS | NS1 | PTP-1D | PTP2C | SH-PTP2 | SH-PTP3 | SHP2 | protein tyrosine phosphatase, non-receptor type 11 | | | 12q24 |
5319 | PLA2G1B | PLA2 | PLA2A | PPLA2 | phospholipase A2 group IB | | | 12q24.31 |
2353 | FOS | AP-1 | C-FOS | p55 | FBJ murine osteosarcoma viral oncogene homolog | | | 14q24.3 |
207 | AKT1 | AKT | CWS6 | PKB | PKB-ALPHA | PRKBA | RAC | RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 | | | 14q32.32 |
5604 | MAP2K1 | CFC3 | MAPKK1 | MEK1 | MKK1 | PRKMK1 | mitogen-activated protein kinase kinase 1 | | | 15q22.1-q22.33 |
5579 | PRKCB | PKC-beta | PKCB | PRKCB1 | PRKCB2 | protein kinase C beta | | | 16p11.2 |
5595 | MAPK3 | ERK-1 | ERK1 | ERT2 | HS44KDAP | HUMKER1A | P44ERK1 | P44MAPK | PRKM3 | p44-ERK1 | p44-MAPK | mitogen-activated protein kinase 3 | | | 16p11.2 |
27040 | LAT | LAT1 | pp36 | linker for activation of T-cells | | | 16p11.2 |
5338 | PLD2 | - | phospholipase D2 | | | 17p13.1 |
2885 | GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | NCKAP2 | growth factor receptor bound protein 2 | | | 17q24-q25 |
8877 | SPHK1 | SPHK | sphingosine kinase 1 | | | 17q25.2 |
5605 | MAP2K2 | CFC4 | MAPKK2 | MEK2 | MKK2 | PRKMK2 | mitogen-activated protein kinase kinase 2 | | | 19p13.3 |
5609 | MAP2K7 | JNKK2 | MAPKK7 | MEK | MEK 7 | MKK7 | PRKMK7 | SAPKK-4 | SAPKK4 | mitogen-activated protein kinase kinase 7 | | | 19p13.3-p13.2 |
1901 | S1PR1 | CD363 | CHEDG1 | D1S3362 | ECGF1 | EDG-1 | EDG1 | S1P1 | sphingosine-1-phosphate receptor 1 | | | 1p21 |
2205 | FCER1A | FCE1A | FcERI | Fc fragment of IgE receptor Ia | | | 1q23 |
5321 | PLA2G4A | PLA2G4 | cPLA2 | cPLA2-alpha | phospholipase A2 group IVA | | | 1q31.1 |
5335 | PLCG1 | NCKAP3 | PLC-II | PLC1 | PLC148 | PLCgamma1 | phospholipase C gamma 1 | | | 20q12-q13.1 |
4773 | NFATC2 | NFAT1 | NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | | | 20q13.2 |
5594 | MAPK1 | ERK | ERK-2 | ERK2 | ERT1 | MAPK2 | P42MAPK | PRKM1 | PRKM2 | p38 | p40 | p41 | p41mapk | p42-MAPK | mitogen-activated protein kinase 1 | | | 22q11.21 |
5894 | RAF1 | CMD1NN | CRAF | NS5 | Raf-1 | c-Raf | Raf-1 proto-oncogene, serine/threonine kinase | | | 3p25 |
868 | CBLB | Cbl-b | Nbla00127 | RNF56 | Cbl proto-oncogene B, E3 ubiquitin protein ligase | | | 3q13.11 |
5290 | PIK3CA | CLOVE | CWS5 | MCAP | MCM | MCMTC | PI3K | p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | | | 3q26.3 |
5062 | PAK2 | PAK65 | PAKgamma | p21 protein (Cdc42/Rac)-activated kinase 2 | | | 3q29 |
5783 | PTPN13 | FAP-1 | PNP1 | PTP-BAS | PTP-BL | PTP1E | PTPL1 | PTPLE | hPTP1E | protein tyrosine phosphatase, non-receptor type 13 | | | 4q21.3 |
4790 | NFKB1 | CVID12 | EBP-1 | KBF1 | NF-kB1 | NF-kappa-B | NF-kappaB | NFKB-p105 | NFKB-p50 | NFkappaB | p105 | p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | | | 4q24 |
4214 | MAP3K1 | MAPKKK1 | MEKK | MEKK 1 | MEKK1 | SRXY6 | mitogen-activated protein kinase kinase kinase 1 | | | 5q11.2 |
5295 | PIK3R1 | AGM7 | GRB1 | IMD36 | p85 | p85-ALPHA | phosphoinositide-3-kinase regulatory subunit 1 | | | 5q13.1 |
5921 | RASA1 | CM-AVM | CMAVM | GAP | PKWS | RASA | RASGAP | p120 | p120GAP | p120RASGAP | RAS p21 protein activator 1 | | | 5q13.3 |
2241 | FER | PPP1R74 | TYK3 | p94-Fer | FER tyrosine kinase | | | 5q21 |
3702 | ITK | EMT | LPFS1 | LYK | PSCTK2 | IL2 inducible T-cell kinase | | | 5q31-q32 |
2534 | FYN | SLK | SYN | p59-FYN | FYN proto-oncogene, Src family tyrosine kinase | | | 6q21 |
7462 | LAT2 | HSPC046 | LAB | NTAL | WBSCR15 | WBSCR5 | WSCR5 | linker for activation of T-cells family member 2 | | | 7q11.23 |
3551 | IKBKB | IKK-beta | IKK2 | IKKB | IMD15 | NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | | | 8p11.2 |
4067 | LYN | JTK8 | p53Lyn | p56Lyn | LYN proto-oncogene, Src family tyrosine kinase | | | 8q13 |
5747 | PTK2 | FADK | FAK | FAK1 | FRNK | PPP1R71 | p125FAK | pp125FAK | protein tyrosine kinase 2 | | | 8q24.3 |
6850 | SYK | p72-Syk | spleen tyrosine kinase | | | 9q22 |
695 | BTK | AGMX1 | AT | ATK | BPK | IMD1 | PSCTK1 | XLA | Bruton tyrosine kinase | | | Xq21.33-q22 |